Hossein Borghaei

27PUBLICATIONS
190CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 30, 2026
Combination AURKA and WEE1 inhibition exhibits efficacy in EGFR or pan-ERBB inhibitor resistant head and neck squamous cell carcinoma.

|Jun 26, 2026
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.

|Jun 08, 2026
Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.

|Jun 03, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

|Feb 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities.

Sonam Puri, Andrew Elliott, Abdul Rafeh Naqash

|Jan 23, 2026
NN-01-195, a Novel Conjugate of HSP90 and AURKA Inhibitors, Effectively Targets Solid Tumors.

Theodore T Nguyen, Nitesh K Nandwana, Yellamelli V V Srikanth

Pageof 5

Frequent Collaborators

5 joint publications

Suresh S Ramalingam

5 joint publications

Luis Paz-Ares

4 joint publications

Karen L Reckamp

4 joint publications

Balazs Halmos